ATIF - DBI ALAR and ATIF are among pre market gainers
2023-09-07 08:45:04 ET
- Wheeler Real Estate Investment ( NASDAQ: WHLR ) +92% .
- ATIF Holdings ( ATIF ) +41% .
- Hitek Global ( HKIT ) +22% .
- Actelis Networks ( ASNS ) +14% .
- CymaBay Therapeutics ( CBAY ) +16% says liver disease candidate outperformed in Phase 3 trial.
- Rosecliff Acquisition ( RCLF ) +14% .
- Alarum Technologies ( ALAR ) +13% .
- Designer Brands ( DBI ) +11% Q2 earnings call release
- Nurix Therapeutics ( NRIX ) +11% Announces Strategic Collaboration with Seagen Combining Industry Leading Technologies of Targeted Protein Degradation and Antibody-Drug Conjugation to Advance an Innovative New Class of Cancer Therapeutics.
- Kodiak Sciences ( KOD ) +9% one-year results for Kodiak's tarcocimab tedromer in the pivotal BEACON trial reinforce durability signal and demonstrate matched efficacy and comparable safety and tolerability in retinal vein occlusion.
For further details see:
DBI, ALAR and ATIF are among pre market gainers